Colorectal Flashcards
(117 cards)
Treatment of Haemorrhoids
Conservative - Stool softness and anasol to reduce pain - likely ineffective
Grade 1-2 - Injection sclerotherapy, laser, RFA (Rafaelo), banding
Grade 2-3 - Banding vs HALO / THD - Hubble trial showed banding cheaper and equally effective but less pain
Grade 3-4 Stapled vs Open - eTHOS trial - open better quality of life
Risks of open haemorrhoidectomy
Pain - analgesia and laxatives as well as 5/7 metronidazole
Bleeding - around 7-14/7 (wound infection)
Infection - unusual
Urinary retention (more common in men)
Stenosis - Late complication - may require dilatation
Faecal incontinence - minor seepage common in early post-operative period
Treatment of fissure
Conservative, fibre, fluids, laxatives, sitz baths
Medication - 2% Diltiazem cream or GTN - twice a day for -8 weeks
Surgical - EUA and Botox
Shown to be effective in 80% of patients
Need to organise Flexi to rule out lesion when fissure healed
Chronic non- healing fissure post Botox
Reassess and confirm diagnosis - rule out underling anal SCC, infection (herpes, syphilis, TB.
Investigate - Physiology studies inc ends-anal ultrasound
Can consider repeat botox or lateral sphincterotomy if fissure confirmed (men initially - females need study)
Lateral Sphincertotomy
GA, Lithotomy
Intersphincteric groove identified and small incision made (11 blade).
Intersphincteric and submucosal planes developed and internal sphincter divided to length of fissure
85% change of healing - 5%risk of faecal seepage or soiling
Non - healing post Lateral Sphinctertomy
Anal manometry studies to assess high vs low pressure
Low presuure - advancement (VY) flap)
High pressure -biofeedback, botox and repeat lateral/opposite side
Rectal cancer found at colonoscopy
Complete Colon, take biospies, rule out synchronous disease. Note size, location, distance from anal verge, fixity and if obstruction. Also anal tone
CT, Chest, abdo, pelvis and MRI rectum
Bloods including baseline and CEA
Use of endoanal US
Consider if early cancer and considering TAMIS, TEMS, TEO
ACPGBI - early rectal cancer T1 - diameter <3cm, no Lymphovascualr invasion and well or moderately differentiated
Low rectal tumour
MRI based - Tumour with lower edge at or below origin of levators at pelvic side wall.
Approx <6cm of anal vegetables
When to use Neoadjuvant Tx in rectal cancer
Not required in resectable cancers no involving CRM (T1-3, N0-2 M)
Needed if high risk of local recurrence (T3c (5-15mminto mesorectum), EMVI or mesolectal LN), tumour involving or beyond the mesolectal fascia
What is long course Chemo-rad for rectal Ca and Short course
45Grays in 25 fractions with synchronous 5FU or oral capecitabine - normally over 6weeks
Restage in 8-12 weeks if patient Fit - PET-CT and MRIcould be considered
Short course is 25Gry over 5 days
TME
Total mesorectal Excision
Optimal surgery - popularised by Prof Heald
Reduces local recurrence and rates of APER
Bowel Prep for L sided resections?
Reduced stool burden and makes stapling easier
Difficult for patients and risk of dehydration or liquid stool if timed poorly
GRECCAR3 2010 showed reduced septic complications with prep, ESCP 2017 showed reduced leak rates with Prep and antibiotics.
American society of colon and rectal surgeons recommends Abx and prep
Nerve injury in pelvic surgery
Ligation of IMA and rectrorectal space - Superior hypogastric plexus or hypogastric nerves
Disection of lateral rectal ligament - Nervi erigentes
Division of Denonvilliers fascia - inferior hypogastric plexus
Perineal dissection - pudendal nerve
Functional outcomes - difficulties in bladder emptying, erectile dysfunction and an-orgasmia
Risk factor for leaks
Male, bulky tumour, DM, pulmonary disease, vascular disease, smoker, obesity, malnutrition, immunocompromised, difficult procedure (Contamination, blood loss, transfusion, use of inotropes, >4hrs)
Anal Cancer Hx
Symptoms - pain, bleeding, pruritus, faecal incontinacne, Anal receptive inercourse, STD, HIV, Cervical or vulval intraepithelial neoplasia in women
Examination - inguinal lymphadenopathy, DRE
Differentials for Anal Cancer
Cancer, fissure, Crohns, Excoriation associated with pruritus Ani, Chancroid, Nicorandil induced anal ulcer
Staging Anal Cancer Ix
Ct chest, abdo, pelvis
MRI pelvis
CT PET - improves loco-regional LN staging and helps planning for radiotherapy - used in high risk (T2–>)
LN Anal SCC
14% of cancers have LN at presentation
>40% not clinically decidable as <5mm
CLN can be reactive or mets
If high uptake on PETCT or MRI then FNA not required
Should be included in Radio unless small T1 lesion
Treatment Anal SCC
Local resection small and T1
All others
Nigro Protocol 50.4Gray radiotherapy with mitomycin -c and 5FU or capecitabine
Possible need for defunctioning stoma
Follow Up Anal SCC
Primary aim to detect disease for surgery Secondary aim is to assess symptoms
Initial Clinical assessment at 6-8 weeks then every 4-8 weeks until clinical and radilogical complete response (can take 6 months)
After complete response - ACT 2 trial
Every 2 months for first year
Every 3 months for second year
Every 6 months 3-5yrs
CT C/A/P first at 12-18months then 24-36 months.
Most failures (Round 80%) occur within 2 years
Recurrent Anal SCC
Reassess, EUA, CT and MRI
Can consider for salvage surgery (50-75%) conversion for persistent or recurrent.
May need radical ischia-anal APER or Exenteration
Distant Mets in Anal SCC
Usually considered palliative
Palliative Chemo - Cisplatib with 5FU or capecitabine
IF small and resectable can occasionally consider resection
FOxTROT trial
Investigate neoadjuvant vs standart post Op Chemo for locally advanced operable colon cancer
6weeks pre-op Oxaliplatin and fluropyrimidine chemo plus post op tx
or
only 24 weeks post op Chemo
Outcomes
Neoadj led to significant down staging, improved Ro reaction, reduced 2yr recurrence rated also less serious post-op complications
Addition of panitumumab offered no extra benefit.